Orchestra BioMed Holdings (OBIO) Shares Outstanding (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Shares Outstanding data on file, last reported at $58.6 million in Q1 2026.

• Quarterly Shares Outstanding rose 53.03% year-over-year to $58.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.6 million (up 53.03% YoY) and the FY2025 annual result came in at $57.0 million, up 49.32% from the prior year.
• Shares Outstanding climbed to $58.6 million in Q1 2026 per OBIO's latest filing, from $57.0 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $58.6 million in Q1 2026 and bottomed at $10.1 million in Q1 2022.
• The 5-year median for Shares Outstanding is $35.8 million (2024), against an average of $36.6 million.
• The widest annual swing landed in 2022, when Shares Outstanding surged 1533.38%; it then climbed 0.23% in 2024.
• Tracing OBIO's Shares Outstanding over 5 years: stood at $35.7 million in 2022, then advanced by 0.23% to $35.8 million in 2023, then rose by 6.76% to $38.2 million in 2024, then surged by 49.32% to $57.0 million in 2025, then grew by 2.8% to $58.6 million in 2026.
• Per Business Quant, the three latest OBIO Shares Outstanding figures stand at $58.6 million (Q1 2026), $57.0 million (Q4 2025), and $56.5 million (Q3 2025).

Peer Comparison